Moderate alcohol consumption appears protective against cardiovascular events and mortality in community-based epidemiologic studies, but whether its consumption affects perioperative outcomes remains unknown. Therefore, the authors tested the hypothesis that alcohol consumption of 3 or more drinks per week improves postoperative outcomes in patients undergoing coronary artery bypass graft (CABG) surgery.
I
N THE UNITED STATES, approximately 50% of the adult population consumes alcohol regularly, and 15 to 20 million people (4.5% of the population) meet the diagnostic criteria for alcohol dependence. 1 Excessive alcohol use is associated with impaired host defenses, bone marrow depression, electrolyte and fluid imbalance, liver disease, respiratory complications, cardiomyopathy, and delirium. 2, 3 In contrast, community-based epidemiologic studies and investigations involving patients requiring critical care suggest that moderate alcohol use may have beneficial effects on mortality, especially in patients with pre-existing coronary artery disease. 4 Whether these potential benefits of alcohol consumption extend to patients undergoing coronary artery bypass graft (CABG) surgery remains unknown. Therefore, the authors tested the hypothesis that alcohol use is associated with a lower incidence of serious complications after CABG surgery. The secondary aim was to determine whether preoperative alcohol use is associated with the duration of hospitalization.
METHODS
All patients undergoing elective CABG surgery at the authors' institution with or without valve surgery from January 1998 through January 2007 were included in this analysis. Patient data were obtained from the Cardiothoracic Anesthesia Patient Registry of the Department of Cardiothoracic Anesthesia using methods that have been reported previously. 5 Research use of this registry was approved by the Institutional Review Board. The Institutional Review Board waived the need for individual informed consent for the purpose of this retrospective analysis. All data were collected daily, concurrent with patient care, on preprinted forms, by experienced and specifically trained research personnel. Data that did not conform within a range of expected results were rejected and re-evaluated.
Patients were excluded for the following: preoperative cardiogenic shock, endocarditis, presence of an intra-aortic balloon pump, extracorporeal membrane oxygenation, preoperative mechanical lung ventilation, presence of a ventricular assist device, emergency or reoperative surgery, and preoperative renal replacement therapy. Alcohol use in this database was defined as Ն3 drinks per week (1 drink ϭ 12 g of alcohol) and nonusers and infrequent users as consuming 0 to 2 drinks per week. Data from 13,065 patients were available for analysis. The composite outcome was defined as the occurrence of any major cardiac, pulmonary, renal, neurologic, intubation-related incidence, serious infection, and mortality. Only major life-threatening morbidity requiring treatment was included. Outcome variables as described by Higgins et al 5 included the following:
1. Mortality (all-cause in-hospital mortality). 2. Cardiac morbidity (combination of postoperative myocardial infarction and/or low cardiac output with a requirement for intra-aortic balloon pump, ventricular assist device, or extracorporeal membrane oxygenation). Postoperative myocardial infarction is defined by specific electrocardiographic findings consistent with myocardial infarction with a creatine phosphokinase myocardial band of Ն50 IU or an aspartate aminotransferase level of Ն80 U/L. Low cardiac output is defined as a cardiac index Ͻ1.8 L/min/m 2 despite adequate fluid replacement and high-dose inotropes for Ͼ4 hours. 3. Neurologic morbidity defined as new postoperative focal (aphasia, decrease in limb function, or hemiparesis confirmed by clinical findings and/or computed tomographic scan) or global neurologic deficit (diffuse encephalopathy with Ͼ24 hours of severely altered mental status and/or failure to awaken postoperatively). 4. Prolonged intubation (duration of intubation Ͼ72 hours).
5. Renal morbidity defined as postoperative anuria or oliguria (urine output Ͻ400 mL/24 hours) and/or institution of renal dialysis or ultrafiltration. 6. Infection morbidity (culture-proven pneumonia, mediastinitis, wound infection, or septicemia with appropriate clinical findings). 7. Overall morbidity (incidence of one or more of the previously described morbidities, including death, because early death precludes observation of morbidity).
PROPENSITY MATCHING AND DATA ANALYSIS
The data were analyzed by using a 2-step process. First, patients who reported alcohol use (Ն3 drinks/wk) were matched to those who reported none or infrequent alcohol use via propensity score matching. 6 The propensity scores were estimated by using stepwise multivariable logistic regression (alpha-to-enter and alpha-to-stay criteria set purposefully conservative at 0.35 because the goal was to obtain maximum predictive ability) with alcohol use as the response and available baseline and intraoperative covariables as potential predictors. A 1-to-1 greedy matching algorithm was then implemented on the propensity scores for alcohol use with 0.05 propensity score units as the maximum allowable distance for matching. Absolute standardized differences (ASDs), defined as the absolute value of the difference in means, mean rankings, or proportions divided by the pooled standard deviation, were used for each potential confounder to compare all-patient and matched-patient groups on balance. Although p values resulting from appropriate statistical tests are dependent on the sample size, the use of ASD enables the direct comparison of balance between the all-patient and matched-patient groups.
The assessment of the relationship between alcohol use and the composite outcome was performed on the propensitymatched subset of patients. Univariate analysis was performed with the Pearson chi-square test. Multivariable logistic regression analysis was then performed to evaluate the risk for the composite outcome for alcohol users compared with non-or infrequent users while adjusting for any potential confounding variables attributable to residual covariable imbalance (covariables included via a stepwise selection routine with alpha-to-enter and alpha-to-stay criteria set at 0.20 and 0.05, respectively).
The hospital length of stay was analyzed as a time-to-event outcome using stepwise Cox regression (alpha-to-enter and alpha-to-stay criteria of 0.20 and 0.05, respectively). To remove informative censoring bias in measuring the length of stay in patients who died in the hospital, such patients were assigned the longest observed length of stay among those who were discharged and marked as censored (ie, not discharged alive) at that time.
With a matched-subset sample size of 4,460 patients and an observed 5.2% incidence of the composite outcome among the infrequent/nondrinker population, there was approximately 54% power to detect an odds ratio of 1.30 or more extreme (eg, an increase in incidence from 5.2% to 6.7%), which was considered as minimum clinical relevance. SAS software version 9.1 (SAS Institute, Cary, NC) and R software version 2.4.1 (The R Foundation for Statistical Computing; http://www. r-project.org/foundation/) were used for all analyses.
RESULTS
The propensity modeling resulted in 2,230 matched patient pairs. (Only 5 of 2,235 alcohol users were not matched.) The propensity model showed a good ability to discriminate alcohol users from nonusers using baseline covariables, with a c-statistic of 0.72. The median (quartiles) of the propensity scores among the matched patients was 0.25 (0.16, 0.32) for each of the alcohol use groups (p Ͼ 0.99, Wilcoxon rank sum test), suggesting multivariate balance on the observed covariables.
Morbid events after CABG surgery for all 13,065 studied patients as well as for 4,460 matched patients are summarized in Table 1 . Demographic and perioperative data for the entire cohort of patients and for the propensity-matched patients used in the analysis are shown in Tables 2 (categoric variables) and 3 (continuous variables). Among the entire cohort, drinkers were more likely to be male; more likely smokers; and less likely to have diabetes, congestive heart failure, or hypertension.
Data from the ASD scores, both before and after propensity matching, are shown in Figure 1 . The ASD scores were better (smaller) for the propensity-matched patients, which is to say that the alcohol use groups were generally closer in central tendency (mean, median, or proportion as appropriate) on the analyzed covariables after propensity matching. In fact, ASD scores were less than 0.1 for all baseline and intraoperative In the primary multivariable logistic regression model (which was fitted to the subset of propensity-matched patients), the odds ratio (95% CI) of the composite outcome for alcohol drinkers versus infrequent/nondrinkers was 1.13 (0.96-1.34, p ϭ 0.14, Table 4 ). Statistically significant interactions between alcohol use and left ventricular function (LVF) and between alcohol use and a history of chronic obstructive pulmonary disease (COPD)/asthma were observed, even after the Bonferroni correction for multiple comparisons (10 two-way interactions involving alcohol use group were examined [ Table 4 ], Bonferroni-adjusted p Ͻ 0.001 for the 2-way interaction involving LVF and p ϭ 0.006 for the 2-way interaction involving COPD/asthma). Among patients with an LVF Ͻ40% and a history of asthma/COPD, the consumption of 3 or more drinks per week was associated with an odds ratio (99.5% CI) of 0.13 (0.04-0.40); among patients with an LVF Ͻ40% and no history of asthma/COPD, the odds ratio was 0.88 (0.57-1.37); among patients with an LVF Ն40% and a history of asthma/COPD, the odds ratio was 1.37 (0.59-3.18); and among patients with an LVF Ն40% and no history of asthma/COPD, the odds ratio was 1.74 (1.20-2.51). However, it is important to note that this interaction was not specified a priori, and, thus, this interaction result is to be regarded as hypothesis generating. Twenty-seven of 2,230 matched drinkers (1.2%) and 22 of 2,230 matched infrequent/nondrinkers (1.0%) died during their hospital stay; these proportions were not significantly different (p ϭ 0.47, Pearson chi-square test). Alcohol use was not associated with the time to hospital discharge. The median (quartiles) adjusted duration of hospitalization was 6 (5, 8) days for both alcohol use groups. In a univariable Cox model, the estimated ratio (95% CI) of discharge rates (comparing drinkers with infrequent/nondrinkers) was 1.02 (0.96, 1.08) (p ϭ 0.59); after adjusting for covariables in a stepwise multivariable Cox model, this ratio estimate was 1.03 (0.97, 1.09) (p ϭ 0.28). 
DISCUSSION
Various studies have shown poor postoperative outcomes in alcohol abusers and heavy drinkers undergoing noncardiac surgery. 2, [7] [8] [9] Cardiac surgery, however, is different form noncardiac surgery both in terms of the baseline health status of patients and the nature of the surgery. Epidemiologic studies have shown a U-shaped relationship between alcohol consumption and mortality, suggesting moderate intensity drinkers fare well as compared with nondrinkers as well as heavy drinkers. 10 Even the American Heart Association recommends that heart patients who consume 1 to 2 alcoholic drinks per day do not need to stop drinking. Therefore, it is reasonable to expect some protective effect of alcohol in patients having cardiac surgery.
The present study showed that the risk for the composite postoperative adverse outcome and the duration of hospitalization were similar between patients who consumed Ն3 drinks of alcohol per week before surgery compared with infrequent or nonusers of alcohol. Thus, alcohol use was not protective in patients having cardiac surgery. The quantity of use causing benefit or harm cannot be determined from the present study. Based on previous studies, however, it still would be wise to recommend abstinence from heavy drinking preoperatively.
Multivariable analysis showed a significant interaction among alcohol use, the composite outcome, and left ventricular ejection fraction and COPD/asthma. This interesting interaction was not a priori-defined outcome, and explanation of this finding is speculative. Studies have shown that alcohol affects cardiac contractility [11] [12] [13] [14] [15] and interferes with neurohormones, which are involved in heart failure. [16] [17] [18] [19] [20] [21] The authors' observation that alcohol use was protective in patients with pre-existing left ventricular dysfunction is thus consistent with previous observations in nonsurgical cohorts. Investigators have also shown that light-to-moderate drinking is a favorable prognostic factor in people with existing left ventricular systolic dysfunction. 22 However, it is equally possible that patients with poor LVF who continue to drink are simply healthier than their nondrinker counterparts.
Studies suggest that the benefits and risks of alcohol use are dose dependent. There is a U-shaped relationship between alcohol consumption and coronary heart disease 23,24 and allcause mortality. 25 A higher amount of alcohol use has been associated with worse cardiac and noncardiac outcomes. 2, 8, 26 For example, Gould et al 11 have shown that Ͼ4 ounces of 80 proof liquor (ϳ3 drinks) per day caused cardiac depression. 11 Higher amounts of alcohol consumption caused hypertension, 27 modulate inflammation to increase wound infection, 28 and increase both cardiovascular and noncardiovascular death. 29 Conversely, the same studies suggested that subjects who drink moderately had a lower risk of CHD and death than either nonusers or heavy drinkers.
Alcohol use has been studied in patients with COPD and asthma and has had mixed results. Evidence suggests a harmful effect of alcohol at the cellular level. 30, 31 The effect of alcohol use on lung mechanics remains unclear. Garshick et al 32 showed an inverse relationship between alcohol use and FEV 1 , whereas 2 other researchers provided evidence that modest alcohol may actually decrease the rate of FEV 1 decline. 33, 34 Overall, research in this area is limited, but considering potential immunomodulatory effects of alcohol such an interaction is certainly hypothesis generating.
From a practical perspective, alcohol use cannot be randomly assigned in large populations, forcing the authors to use an observational design. Therefore, the major limitation of the present analysis is its retrospective cohort design, with the consequence that alcohol use was inadequately quantified, potential confounding factors were not necessarily available, and there was not optimum power to detect a clinically significant difference. It should be especially noted that self-reports underestimate alcohol consumption and that validity is worst among heavy drinkers. 35, 36 Because alcohol consumption was recorded only as Ն3 drinks per week, the group of users presumably includes a wide range of drinkers, including alcohol abusers. Heavy drinkers could not be separated from moderate users of alcohol in the present study. It also is possible that some abstainers were former drinkers who quit because of ill health. However, studies have shown that former drinkers and life-long abstainers have a similarly elevated risk of coronary heart disease. 37, 38 In summary, patients consuming Ն3 drinks per week and those consuming 0 to 2 drinks per week did not differ significantly on overall postoperative outcomes. This result, however, comes with the primary limitations that heavy and moderate drinkers were not separately studied and that this was a retrospective analysis. The effect of preoperative alcohol consumption on outcomes after CABG surgery appeared to have an association with LVF and COPD/asthma.
